Investors & Media

Press Release

Printer Friendly Version View printer-friendly version

<< Back

BIO Welcomes bluebird bio CEO Nick Leschly to the Health Section Governing Board

BIO Welcomes New Executive Committee and Section Governing Board Members

2012 BIO International Convention

WASHINGTON -- The Board of Directors of the Biotechnology Industry Organization (BIO) elected its Executive Committee and added new members to Section Governing Boards in a meeting held in conjunction with the 2012 BIO International Convention, the global event for biotechnology, taking place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.

“We are pleased to welcome the new members of the Executive Committee and Section Governing Boards,” stated BIO President and CEO Jim Greenwood. “Their new perspectives and ideas are valuable additions to the collective expertise of the BIO Board as we advocate for public policy in the U.S. and around the world that encourages the research and development necessary for continued innovation in breakthrough medical therapies, enhanced agricultural products and revolutionary biofuels.”

H. Thomas Watkins, President and CEO of Human Genome Sciences, Inc., will continue to serve as the Chair of the Board of Directors and of the Health Section Governing Board.

...

The full BIO Board of Directors is comprised of the elected Directors serving on each of BIO’s Section Governing Boards (Emerging Companies, Food and Agriculture, Health, and Industrial and Environmental). The newly-elected Board Members from these sections are:

Health Section Governing Board
Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc.
Jeff Leiden, President & CEO, Vertex Pharmaceuticals Incorporated
Nick Leschly, President & CEO, bluebird bio
Kenneth Moch, President & CEO, Chimerix, Inc.
John Orwin, Chief Executive Officer, Affymax, Inc.
Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc Henri Termeer, Chair Emeritus

...

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

Media Contact

Stephanie Fagan

Senior Vice President, Corporate Communications

(201) 572-9581

sfagan@bluebirdbio.com

 

Investor Contact

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com